About 200 reports

Major companies in the musculoskeletal disorders drugs market include F. Hoffmann-La Roche Ltd; GlaxosmithKline Plc; Pfizer Inc; Abbott Laboratories Inc and Daiichi Sankyo Company. The global musculoskeletal disorders drugs market is expected to grow from $81.08 billion in 2020 to $85.6 billion in 2021 at a compound annual growth rate...

  • Musculoskeletal Disorder
  • World
  • Health Expenditure
  • Drug Approval

Osteopetrosis (Musculoskeletal Disorders) - Drugs in Development, 2021 Summary Osteopetrosis (Musculoskeletal Disorders) - Drugs in Development, 2021 provides an overview of the Osteopetrosis pipeline landscape. The report provides comprehensive information on the therapeutics under development...

  • Musculoskeletal Disorder
  • World

Polymyositis (Musculoskeletal Disorders) - Drugs in Development, 2021 Summary Polymyositis (Musculoskeletal Disorders) - Drugs in Development, 2021 provides an overview of the Polymyositis pipeline landscape. The report provides comprehensive information on the therapeutics under development...

  • Musculoskeletal Disorder
  • Autoimmune Disease
  • World

Muscle Injury (Musculoskeletal Disorders) - Drugs in Development, 2021 Summary Muscle Injury (Musculoskeletal Disorders) - Drugs in Development, 2021 provides an overview of the Muscle Injury pipeline landscape. The report provides comprehensive information on the therapeutics under development...

  • Musculoskeletal Disorder
  • World

Mitochondrial Myopathy (Musculoskeletal Disorders) - Drugs in Development, 2021 Summary Mitochondrial Myopathy (Musculoskeletal Disorders) - Drugs in Development, 2021 provides an overview of the Mitochondrial Myopathy pipeline landscape. The report provides comprehensive information on the...

  • Neurological Disorder
  • Musculoskeletal Disorder
  • World

Bone Disorders (Musculoskeletal Disorders) - Drugs in Development, 2021 Summary Bone Disorders (Musculoskeletal Disorders) - Drugs in Development, 2021 provides an overview of the Bone Disorders pipeline landscape. The report provides comprehensive information on the therapeutics under development...

  • Musculoskeletal Disorder
  • World

Knee Osteoarthritis (Musculoskeletal Disorders) - Drugs in Development, 2021 Summary Knee Osteoarthritis (Musculoskeletal Disorders) - Drugs in Development, 2021 provides an overview of the Knee Osteoarthritis pipeline landscape. The report provides comprehensive information on the therapeutics...

  • Musculoskeletal Disorder
  • Arthritis
  • World

Muscle Wasting Disorders (Musculoskeletal Disorders) - Drugs in Development, 2021 Summary Muscle Wasting Disorders (Musculoskeletal Disorders) - Drugs in Development, 2021 provides an overview of the Muscle Wasting Disorders pipeline landscape. The report provides comprehensive information...

  • Musculoskeletal Disorder
  • World

Facioscapulohumeral Muscular Dystrophy (FSHD) (Musculoskeletal Disorders) - Drugs in Development, 2021 Summary Facioscapulohumeral Muscular Dystrophy (FSHD) (Musculoskeletal Disorders) - Drugs in Development, 2021 provides an overview of the Facioscapulohumeral Muscular Dystrophy (FSHD) pipeline...

  • Neurological Disorder
  • Musculoskeletal Disorder
  • World

Limb-Girdle Muscular Dystrophy (Musculoskeletal Disorders) - Drugs in Development, 2021 Summary Limb-Girdle Muscular Dystrophy (Musculoskeletal Disorders) - Drugs in Development, 2021 provides an overview of the Limb-Girdle Muscular Dystrophy pipeline landscape. The report provides comprehensive...

  • Neurological Disorder
  • Musculoskeletal Disorder
  • World

Polyarticular Juvenile Idiopathic Arthritis (PJIA) (Musculoskeletal Disorders) - Drugs in Development, 2021 Summary Polyarticular Juvenile Idiopathic Arthritis (PJIA) (Musculoskeletal Disorders) - Drugs in Development, 2021 provides an overview of the Polyarticular Juvenile Idiopathic Arthritis (PJIA)...

  • Musculoskeletal Disorder
  • World

Drugs to Modulate PPAR-Delta for Metabolic and Musculoskeletal Disorders – Drug Profile

  • Therapy
  • Musculoskeletal Disorder
  • Gene Therapy
  • World

Muscle Stimulator Market Size, Share & Trends Analysis Report By Modality (Handheld, Portable), By Product, By Application (Pain Management, Musculoskeletal Disorder), By End Use, By Region, And Segment Forecasts, 2020 - 2027 The global muscle stimulator market size is anticipated to reach USD 910.2 million by 2027,...

  • Analgesic
  • Musculoskeletal Disorder
  • World
  • Musculoskeletal Disorders Prevalence
  • Health Expenditure

Small Molecules to Agonize Retinoic Acid Receptor Gamma for Musculoskeletal Disorders – Drug Profile

  • Musculoskeletal Disorder
  • Autoimmune Disease
  • World
  • South Africa
  • Drug Approval
  • Smoking Prevalence

Small Molecules to Inhibit Pan-RAF Kinase Musculoskeletal Disorders and Oncology – Drug Profile

  • Oncology
  • Pharmaceutical
  • Musculoskeletal Disorder
  • World
  • Pharmaceutical Registrations

World Therapy Musculoskeletal Disorder

  • Musculoskeletal Disorder
  • World
  • Pharmaceutical Registrations
  • Drug Approval

Small Molecules to Agonize Retinoic Acid Receptor Gamma for Musculoskeletal Disorders – Drug Profile

  • Musculoskeletal Disorder
  • Anti-Infective
  • World
  • South Africa
  • Drug Approval
  • Smoking Prevalence

## Musculoskeletal Disorder Management

  • Analgesic
  • Neuromodulation Device
  • Musculoskeletal Disorder
  • Research And Development
  • Infectious Disease
  • APAC
  • World
  • Europe
  • North America
  • Drug Approval
  • Health Expenditure

World Musculoskeletal Disorder Therapy

  • Musculoskeletal Disorder
  • World
  • Pharmaceutical Registrations
  • Drug Approval

World Musculoskeletal Disorder Arthritis

  • Musculoskeletal Disorder
  • Arthritis
  • World
  • China
  • Jiangsu
  • Drug Approval
  • Cause-Specific Mortality Rate

World Musculoskeletal Disorder Therapy

  • Musculoskeletal Disorder
  • World
  • Pharmaceutical Registrations
  • Mortality Rate

Small Molecules ## to Agonize Retinoic Acid Receptor Gamma for Musculoskeletal Disorders – Drug Profile

  • Musculoskeletal Disorder
  • Anti-Infective
  • World
  • South Africa
  • Drug Approval
  • Smoking Prevalence

World Arthritis Musculoskeletal Disorder

  • Musculoskeletal Disorder
  • Arthritis
  • World
  • China
  • Jiangsu
  • Sweden
  • Cause-Specific Mortality Rate
  • Drug Approval

The Global Digital Therapeutic (DTx) Market is poised to grow at a CAGR of around XX% over the next decade to reach approximately $XX million by 2028. Some of the prominent trends that the market is witnessing include increasing focus on preventive healthcare, unexplored therapeutic applications and large undiagnosed...

  • Pharmaceutical
  • Musculoskeletal Disorder
  • Neurology
  • Addiction Disorder
  • Respiratory Disease
  • Smoking Cessation
  • Cardiovascular Disease
  • Gastrointestinal Drug
  • Diabetes
  • World

Clinical Trials by G## Countries: Proportion of Degenerative Scoliosis to Musculoskeletal Disorders Clinical Trials

  • Musculoskeletal Disorder
  • World

## Musculoskeletal Disorder Management

  • Neuromodulation Device
  • Analgesic
  • Musculoskeletal Disorder
  • North America
  • Drug Approval
  • Medical Devices Sales

Drugs to Modulate PPAR-Delta for Metabolic and Musculoskeletal Disorders – Drug Profile

  • Arthritis
  • New York
  • Pharmaceutical Registrations
  • Drug Approval

World Musculoskeletal Disorder Therapy

  • Musculoskeletal Disorder
  • World
  • Pharmaceutical Registrations
  • Biologics Penetration Rate

## Musculoskeletal Disorder Management

  • Analgesic
  • Neuromodulation Device
  • Musculoskeletal Disorder
  • APAC
  • Drug Approval
  • Disposable Income

World United States Canada Manufacturing Inventory Musculoskeletal Disorder

  • Musculoskeletal Disorder
  • World
  • South Africa
  • Pharmaceutical Registrations
  • Smoking Prevalence